RYAN NISWANDER: Open Payments
NPI 1477890176 · LAWRENCEBURG, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 24 payments from 10 companies in 2025. Trend: 2023 $699 · 2024 $740 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $145 |
| Axsome Therapeutics, Inc. | 3 | $91 |
| Exact Sciences Corporation | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
| Astellas Pharma US Inc | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: Auvelity, QULIPTA, VRAYLAR, Cologuard Collection Kit, JARDIANCE, Veozah, FARXIGA, CAPLYTA.
Industry payments across TN — which companies pay providers there.
